THE SYNERGISTIC POWER OF GHRPs AND CJC-1295
Please Read our Disclaimer
Growth Hormone is responsible for several metabolic functions from early life to adulthood. Unfortunately, its secretion declines with aging, leading to growth hormone deficiency. Peptide therapy, such as CJC-1295 and Ipamorelin, can address growth hormone deficiency and improve overall health by stimulating growth hormone production.
This review summarizes the synergistic power of GHRPs and CJC-1295 in GH replacement, as seen in research using animal models.
Understanding Growth Hormone
Growth hormone (GH) is a vital hormone produced by the pituitary gland that plays a crucial role in regulating growth, development, and metabolism. GH stimulates the production of insulin-like growth factor-1 (IGF-1), which promotes cell growth and division. Additionally, GH helps regulate body composition, bone density, and muscle mass. As we age, our GH levels naturally decline, leading to decreased muscle mass, bone density, and metabolism. This decline can contribute to various age-related health issues, such as osteoporosis, decreased muscle strength, and increased body fat. Understanding the importance of GH and its impact on our bodies can help us appreciate the potential benefits of therapies aimed at boosting GH levels.
Understanding GHRPs: Their Role in Growth Hormone Therapy
Growth Hormone Releasing Peptides, including growth hormone releasing peptide (GHRP-6), are synthetic, non-natural peptides used in growth hormone therapy to secrete GH release from rat pituitary cells. They don’t have any structural similarities with Growth Hormone Releasing Hormone and act through specific receptors present either at the pituitary or the hypothalamic level both in animals.
Some of the GHRPs available for animal studies include GHRP-6, GHRP-1, GHRP-2, Hexarelin, and even the non-peptidyl GHRP known as MK-677.
The GH-releasing effect of GHRPs does not depend on sex but undergoes age-related variations. It increases from birth to adulthood and decreases afterward. However, the activity of GHRPs is still higher than that of GHRH. This is why, when used together, they could synergistically stimulate GH release.
MECHANISM OF ACTION
Animal studies show that GHRPs stimulate growth hormone secretion by blocking somatostatinergic activity at the pituitary and the hypothalamic level through a GHRH-mediated mechanism. However, the possibility that GHRPs act through an unknown hypothalamic factor is still open. The research found that these peptides release GH without affecting the negative feedback mechanisms in the GH pathway, which include somatostatin and IGF-1.
WHAT IS CJC-1295
CJC-1295 is a synthetic analog of the human Growth Hormone-Releasing Hormone, with a substitution of four amino acids that render the compound more resistant to proteolytic inactivation by dipeptidyl peptidase IV (DPP-IV). It covalently binds to endogenous albumin after subcutaneous administration, thereby extending its half-life and duration of action by stimulating growth hormone release.
Studies in animals (rats, pigs, and dogs) show that several days after a single administration of CJC-1295, serum IGF-I levels are still increased. In a recent report, CJC-1295 administered to healthy subjects caused a sustained dose-dependent stimulation of serum GH and IGF-I levels when injected at intervals of 1-2 weeks.
MECHANISM OF ACTION
CJC-1295 is a GHRH mimetic. It stimulates the pituitary gland to release growth hormone from somatotropic cells, increasing plasma levels of growth hormone in animal test subjects without altering its normal pulsation. It doesn’t inhibit the effects of somatostatin.
This is why GHRH products can’t be integrated for anabolic purposes unless they are combined with a GHRP.
GHRPs AND CJC-1295 COMBINED
There is a marked age-related decline in GH secretion in both sexes. GH replacement may be successful in reversing many structural and functional abnormalities. It seems a potentially reasonable approach to prevention or even reversal of the frailty symptoms of aging. It is postulated that GH treatment could also improve muscle strength and functional performance, promoting muscle growth.
In principle, treatment with peptides should offer a more physiologic approach to GH replacement, leading to a pulsatile rather than prolonged elevation in GH and preserving the capability for negative feedback inhibition of GH by rising levels of IGF-1.
While the effects of these two peptides differ clinically, they have synergistic effects on GH release, and therefore supplementation of both substances may be more effective than either alone.
BENEFITS OF INCREASED GROWTH HORMONE LEVELS
Aging is not a disease. It is a physiological state of relative GH deficiency. The combined use of GHRPs and CJC-1295 may result in several anecdotal benefits, as shown in research studies such as:
Increased muscle mass
Increased strength
Decreased body fat
Improved quality of sleep
Increased bone density
Improves immune function
Improved skin elasticity
Improved tissue repair post-injury
Enhanced fat metabolism: Increased growth hormone levels can improve fat metabolism, promoting muscle growth and regulating body composition.
Safety and Side Effects of CJC-1295
CJC-1295 is generally considered safe and well-tolerated when used as directed. However, as with any medication, potential side effects may occur. Common side effects of CJC-1295 include injection site reactions (redness, swelling, or itching), headaches, dizziness, fatigue, and nausea. While these side effects are typically mild and temporary, it is essential to monitor for any adverse reactions.
Rare but more serious side effects may include water retention, joint pain, elevated blood sugar levels, and allergic reactions. It is crucial to consult with a healthcare professional before starting CJC-1295 therapy to discuss potential risks and benefits. By doing so, you can ensure that you are using the peptide safely and effectively, minimizing the risk of adverse effects.
Who is a Good Candidate for CJC-1295?
CJC-1295 is suitable for individuals looking to improve their overall health and well-being, particularly those experiencing age-related decline in growth hormone production. Good candidates for CJC-1295 include adults over 30 years old, individuals with decreased muscle mass and strength, those experiencing decreased bone density, people with impaired glucose metabolism, and individuals seeking to improve their overall quality of life.
However, CJC-1295 may not be suitable for everyone, particularly those with certain medical conditions or taking specific medications. It is crucial to consult with a healthcare professional to determine if CJC-1295 is right for you. By doing so, you can ensure that you are making an informed decision about your health and well-being.
How to Administer CJC-1295
CJC-1295 is typically administered via subcutaneous injection, usually in the abdominal area. The recommended dosage and frequency of administration may vary depending on individual needs and health status. It is essential to follow the guidance of a healthcare professional to ensure proper administration and minimize potential side effects.
To administer CJC-1295 safely and effectively:
Use a sterile needle and syringe
Inject the medication into the fatty tissue of the abdominal area
Rotate injection sites to minimize the risk of injection site reactions
Follow the recommended dosage and frequency of administration
Monitor for potential side effects and report them to your healthcare professional
By understanding growth hormone, being aware of potential side effects, identifying suitable candidates, and following proper administration guidelines, individuals can safely and effectively use CJC-1295 to promote muscle growth, fat loss, and overall health.
CONCLUSION
Given the potential risks of exogenous GH use, alternative therapies using a combination of GHRPs and CJC-1295, that avoid these risks, would be welcome additions in the management of GH-deficient animals. They may have the advantage of a more physiological approach with theoretically decreased risk for side effects.
LOOKING FOR WHERE TO BUY PEPTIDES
You can purchase GHRPs and CJC-1295 from Loti Labs. Buy peptides which are USA-made for the integrity of your research. Integrating a healthy diet can enhance the effectiveness of peptide therapy. They are tested through HPLC and Mass spectrometry to ensure quality.
Alba, M. et al. (2006). Once-daily administration of CJC-1295, a long-acting growth hormone-releasing hormone (GHRH) analog, normalizes growth in the GHRH knockout mouse. American Journal of Physiology, Endocrinology, and Metabolism.
Jette, L. et al. (2005). hGRF1-29-albumin bioconjugates activate the GRF receptor on the anterior pituitary in rats: Identification of CJC-1295 as a long-lasting GRF analog. Endocrinology.
Benquet, C. et al. (2004). (CJC-1295 (DAC-GRF), a long-acting GRF analog, enhances pulsatile GH secretion, increases IGF-I levels, and restores linear growth. Program of the 86th Annual Meeting of the Endocrine Society, New Orleans, LA, p 491 (Abstract P3-109).
Ghigo, E., Arvat, E., Muccioli, G., & Camanni, F. (1997). Growth hormone-releasing peptides, European Journal of Endocrinology, 136(5), 445-460. Retrieved Jan 19, 2020, from https://eje.bioscientifica.com/view/journals/eje/136/5/eje_136_5_001.xml
Hersch, E. C., & Merriam, G. R. (2008). Growth hormone (GH)-releasing hormone and GH secretagogues in normal aging: Fountain of Youth or Pool of Tantalus?. Clinical interventions in aging, 3(1), 121–129.
Sigalos, J. T., & Pastuszak, A. W. (2018). The Safety and Efficacy of Growth Hormone Secretagogues. Sexual medicine reviews, 6(1), 45–53. doi:10.1016/j.sxmr.2017.02.004
